Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells
- 20 January 2012
- journal article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 134 (1), 139-155
- https://doi.org/10.1007/s10549-011-1944-x
Abstract
We investigated the role of human natural killer (NK) cells in the peripheral blood (PB) and liver in controlling breast cancer. The proportion of NK cells among liver mononuclear cells was significantly higher than among PB mononuclear cells. Liver NK cells inductively expressed higher levels of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) than PB NK cells in response to interleukin-2 (IL-2). Liver NK cells displayed higher cytotoxicity against various breast cancer cell lines (MDA-MB231, MDA-MB453, MDA-MB468, and MCF-7) after IL-2 stimulation than did PB NK cells. Anti-HER2 monoclonal antibody (mAb) promoted the cytotoxicity of both the types of NK cells toward HER2-expressing cell lines. All breast cancer cell lines highly expressed death-inducing TRAIL receptors, death receptor 4, but did not express death-inhibitory receptors (DcR1 and DcR2). Both PB and liver NK cell-induced cytotoxicity was inhibited partially by anti-TRAIL mAb and more profoundly by the combination of anti-TRAIL mAb and concanamycin A, indicating that TRAIL and perforin are involved. IL-2-stimulated liver and PB NK cells exhibited upregulated expression of CXCR3, which bind to the chemokines CXCL9, CXCL10, and CXCL11 secreted by breast cancer cells. We also found that IFN-γ promoted the production of CXCL10 from breast cancer cells. The results of this study show that IFN-γ secreted from NK cells likely promotes the production of CXCL10 from breast cancer cells, which in turn accelerates the migration of CXCR3-expressing NK cells into the tumor site. These findings suggest the possibility of a therapeutic approach by either activation of endogenous PB and liver NK cells or adoptive transfer of in vitro-activated autologous NK cells.Keywords
This publication has 46 references indexed in Scilit:
- Pluripotent stem cell-derived natural killer cells for cancer therapyTranslational Research, 2010
- Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy – a case reportJournal of Translational Medicine, 2009
- The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancerActa Oncologica, 2009
- TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotypeBreast Cancer Research and Treatment, 2008
- Safety and antitumor activity of recombinant soluble Apo2 ligandJCI Insight, 1999
- Engraftment of Bone Marrow from Severe Combined Immunodeficient (SCID) Mice Reverses the Reproductive Deficits in Natural Killer Cell–deficient tgε26 MiceThe Journal of Experimental Medicine, 1998
- Early Murine Cytomegalovirus (MCMV) Infection Induces Liver Natural Killer (NK) Cell Inflammation and Protection Through Macrophage Inflammatory Protein 1α (MIP-1α)–dependent PathwaysThe Journal of Experimental Medicine, 1998
- Apoptosis by Death FactorCell, 1997
- Strange brew: T cells in the liverImmunology Today, 1996
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987